What is Rocket Pharmaceuticals, Inc. Common Stock's Market Cap?

Rocket Pharmaceuticals, Inc. Common Stock's Market Cap is $407.3M, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Rocket Pharmaceuticals, Inc. Common Stock's Enterprise Value is $144.8M, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Rocket Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Rocket Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Rocket Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$17.3M, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's EBITDA?

Rocket Pharmaceuticals, Inc. Common Stock's EBITDA is -$184.0M, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Rocket Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.16, based on as-reported figures from SEC (XBRL) filings.

What is Rocket Pharmaceuticals, Inc. Common Stock's Net Debt?

Rocket Pharmaceuticals, Inc. Common Stock's Net Debt is -$262.5M, based on as-reported figures from SEC (XBRL) filings.

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Financial Statements

Rocket Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T92156

XNAS · usd

3.71▼ 0.15 (-3.89%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close3.86

Day's Range3.68 – 3.78

52-Week Range2.53 – 5.46

Volume753.9K

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees202

ExchangeXNAS

Listed2015-02-18

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Rocket Pharmaceuticals, Inc. Common Stock (RCKT)

What is Rocket Pharmaceuticals, Inc. Common Stock's Market Cap?: Rocket Pharmaceuticals, Inc. Common Stock's Market Cap is $407.3M, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Rocket Pharmaceuticals, Inc. Common Stock's Enterprise Value is $144.8M, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Rocket Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Rocket Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Rocket Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$17.3M, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's EBITDA?: Rocket Pharmaceuticals, Inc. Common Stock's EBITDA is -$184.0M, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Rocket Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -0.16, based on as-reported figures from SEC (XBRL) filings.
What is Rocket Pharmaceuticals, Inc. Common Stock's Net Debt?: Rocket Pharmaceuticals, Inc. Common Stock's Net Debt is -$262.5M, based on as-reported figures from SEC (XBRL) filings.